214 related articles for article (PubMed ID: 26813784)
1. Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.
Ruhaak LR; Kim K; Stroble C; Taylor SL; Hong Q; Miyamoto S; Lebrilla CB; Leiserowitz G
J Proteome Res; 2016 Mar; 15(3):1002-10. PubMed ID: 26813784
[TBL] [Abstract][Full Text] [Related]
2. Serum glycome profiling: a biomarker for diagnosis of ovarian cancer.
Biskup K; Braicu EI; Sehouli J; Fotopoulou C; Tauber R; Berger M; Blanchard V
J Proteome Res; 2013 Sep; 12(9):4056-63. PubMed ID: 23889230
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.
Kim K; Ruhaak LR; Nguyen UT; Taylor SL; Dimapasoc L; Williams C; Stroble C; Ozcan S; Miyamoto S; Lebrilla CB; Leiserowitz GS
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):611-21. PubMed ID: 24557531
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling.
Dhar C; Ramachandran P; Xu G; Pickering C; Čaval T; Wong M; Rice R; Zhou B; Srinivasan A; Aiyetan P; Chu CW; Moser K; Herzog TJ; Olawaiye AB; Jacob F; Serie D; Lindpaintner K; Schwarz F
Br J Cancer; 2024 Jun; 130(10):1716-1724. PubMed ID: 38658783
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer.
Wieczorek M; Braicu EI; Oliveira-Ferrer L; Sehouli J; Blanchard V
Front Immunol; 2020; 11():654. PubMed ID: 32477323
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
[TBL] [Abstract][Full Text] [Related]
7. Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin.
Stiekema A; Boldingh QJ; Korse CM; van der Noort V; Boot H; van Driel WJ; Kenter GG; Lok CA
Gynecol Oncol; 2015 Mar; 136(3):562-6. PubMed ID: 25560808
[TBL] [Abstract][Full Text] [Related]
8. Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC).
Rohr I; Braicu EI; En-Nia A; Heinrich M; Richter R; Chekerov R; Dechend R; Heidecke H; Dragun D; Schäfer R; Gorny X; Lindquist JA; Brandt S; Sehouli J; Mertens PR
Cytokine; 2016 Sep; 85():157-64. PubMed ID: 27371774
[TBL] [Abstract][Full Text] [Related]
9. Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis.
Bandiera E; Zanotti L; Fabricio AS; Bucca E; Squarcina E; Romani C; Tassi R; Bignotti E; Todeschini P; Tognon G; Romagnolo C; Gion M; Sartori E; Maggino T; Pecorelli S; Ravaggi A
Clin Chem Lab Med; 2013 Sep; 51(9):1815-24. PubMed ID: 24013103
[TBL] [Abstract][Full Text] [Related]
10. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
[TBL] [Abstract][Full Text] [Related]
11. UPLC-MS/MS based diagnostics for epithelial ovarian cancer using fully sialylated C4-binding protein.
Tanabe K; Matsuo K; Miyazawa M; Hayashi M; Ikeda M; Shida M; Hirasawa T; Sho R; Mikami M
Biomed Chromatogr; 2018 May; 32(5):e4180. PubMed ID: 29265394
[TBL] [Abstract][Full Text] [Related]
12. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics.
Odunsi K; Wollman RM; Ambrosone CB; Hutson A; McCann SE; Tammela J; Geisler JP; Miller G; Sellers T; Cliby W; Qian F; Keitz B; Intengan M; Lele S; Alderfer JL
Int J Cancer; 2005 Feb; 113(5):782-8. PubMed ID: 15499633
[TBL] [Abstract][Full Text] [Related]
13. Identification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery.
Schwedler C; Kaup M; Weiz S; Hoppe M; Braicu EI; Sehouli J; Hoppe B; Tauber R; Berger M; Blanchard V
Anal Bioanal Chem; 2014 Nov; 406(28):7185-93. PubMed ID: 25234305
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum CCL18 as a potential biomarker for ovarian cancer.
Yuan L; Wan J; Huang C; Liang J; Liu M; Yue C; Li L
Cancer Biomark; 2017 Dec; 21(1):97-104. PubMed ID: 29036787
[TBL] [Abstract][Full Text] [Related]
15. [Discrimination and clinical value of plasma metabolomic profiles in multidrug resistant epithelial ovarian cancer].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):896-902. PubMed ID: 29262505
[No Abstract] [Full Text] [Related]
16. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.
Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M
J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852
[TBL] [Abstract][Full Text] [Related]
17. Secretome-based identification of TFPI2, a novel serum biomarker for detection of ovarian clear cell adenocarcinoma.
Arakawa N; Miyagi E; Nomura A; Morita E; Ino Y; Ohtake N; Miyagi Y; Hirahara F; Hirano H
J Proteome Res; 2013 Oct; 12(10):4340-50. PubMed ID: 23805888
[TBL] [Abstract][Full Text] [Related]
18. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
[TBL] [Abstract][Full Text] [Related]
19. Multiple Reaction Monitoring for the Quantitation of Serum Protein Glycosylation Profiles: Application to Ovarian Cancer.
Miyamoto S; Stroble CD; Taylor S; Hong Q; Lebrilla CB; Leiserowitz GS; Kim K; Ruhaak LR
J Proteome Res; 2018 Jan; 17(1):222-233. PubMed ID: 29207246
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.
Arakawa N; Kobayashi H; Yonemoto N; Masuishi Y; Ino Y; Shigetomi H; Furukawa N; Ohtake N; Miyagi Y; Hirahara F; Hirano H; Miyagi E
PLoS One; 2016; 11(10):e0165609. PubMed ID: 27798689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
